Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis.

Paul D Miller John P Bilezikian Lorraine A Fitzpatrick Bruce H Mitlak Eugene V McCloskey Felicia Cosman Henry G Bone

Published in: Current medical research and opinion (2020)

ABL is an effective and well-tolerated treatment for women with postmenopausal osteoporosis at high risk for fracture. Its therapeutic effects are sustained with subsequent ALN therapy.

Keyphrases

bone mineral density
postmenopausal women
stem cells
tyrosine kinase
combination therapy
replacement therapy